Nanobiotix S.A. Income Statement

Income Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.00M0.06M0.01M19.64M32.51M12.41M
Gross Profit 0.00M-0.03M-0.09M19.64M32.44M12.41M
Operating items
Research & Development -0.00M-27.78M-35.95M-34.40M-41.53M-43.32M
Selling, General & Administrative -0.00M-16.68M-23.00M-18.82M-23.85M-21.94M
Other Operating Expenses -6.41M-1.04M-2.75M-0.14M
Operating Expenses -0.00M-44.46M-65.35M-54.26M-68.13M-65.40M
Operating Income -0.00M-41.59M-62.22M-49.22M-28.97M-73.08M
EBIT -0.00M-41.59M-62.22M-49.22M-28.97M-73.08M
Non-operating items
Interest & Investment Income -0.00M0.23M7.53M3.72M2.17M8.39M
Non Operating Income 0.00M0.00M
Net income details
EBT -0.00M-44.38M-53.77M-30.89M-10.79M-56.69M
Profit After Tax -0.00M-38.35M-55.62M-60.12M-42.94M-72.81M
Income from Continuing Operations -0.00M-44.38M-53.77M-30.89M-10.79M-56.69M
Consolidated Net Income -0.00M-44.38M-53.77M-30.89M-10.79M-56.69M
Income towards Parent Company -0.00M-44.38M-53.77M-30.89M-10.79M-56.69M
Net Income towards Common Stockholders -0.00M-44.38M-53.77M-30.89M-10.79M-56.69M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 32.54M32.54M34.83M34.88M35.23M47.43M
EBITDA -0.00M-41.59M-62.22M-49.22M-28.97M-73.08M